Evaluation of the Express Plus Range (express plus)
A Study To Evaluate The Acceptability Of the Express Plus Range, Foods For Special Medical Purposes (FSMP), In Children And Adults With Inborn Errors of Metabolism (IEM)
Sponsor: Vitaflo International, Ltd
Listed as NCT05051657, this NA trial focuses on Glutaric Acidemia I and Hereditary Tyrosinemia and remains completed. Sponsored by Vitaflo International, Ltd, it has been updated 11 times since 2021, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Feb 2026 — Present [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Dec 2025 — Feb 2026 [monthly]
Active Not Recruiting NA
-
Jun 2025 — Dec 2025 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Mar 2025 — Jun 2025 [monthly]
Recruiting NA
-
Dec 2024 — Mar 2025 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Sep 2024 — Dec 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Mar 2024 — Jul 2024 [monthly]
Recruiting NA
-
May 2023 — Mar 2024 [monthly]
Recruiting NA
-
Sep 2022 — May 2023 [monthly]
Recruiting NA
-
Oct 2021 — Sep 2022 [monthly]
Recruiting NA
First recorded
Jun 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Vitaflo International, Ltd
For direct contact, visit the study record on ClinicalTrials.gov .